No article text was recorded for this version.
radiographic pseudoprogression
Version 2 of 231 papers48 conceptsfrozen 2026-10-04
Papers in this version
- Blog: FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
- Blog: [Pseudoprogression caused by first-line treatment of classical Hodgkin's lymphoma with PD-1 inhibitor: a case report and literature review].
- Blog: Perspectives on Immunotherapy of Metastatic Colorectal Cancer
- Blog: Proceedings of the International Cancer Imaging Society Meeting and 21st Annual Teaching Course
- Blog: Paradoxical Response to Neoadjuvant Therapy in Undifferentiated Pleomorphic Sarcoma: Increased Tumor Size on MRI Associated with Favorable Pathology
- Blog: A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy
- Blog: Artificial intelligence in cancer imaging for diagnosis and evaluation of treatment response
- Blog: Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience
- Blog: Development and validation of nomogram for predicting pathological complete response to neoadjuvant chemotherapy and immunotherapy for locally advanced gastric cancer: a multicenter real-world study in China
- Blog: Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
- Blog: Amino acid PET vs. RANO MRI for prediction of overall survival in patients with recurrent high grade glioma under bevacizumab therapy
- Blog: Glioblastoma and radiotherapy: A multicenter AI study for Survival Predictions from MRI (GRASP study)
- Blog: Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice
- Blog: Fully automated analysis combining [18F]-FET-PET and multiparametric MRI including DSC perfusion and APTw imaging: a promising tool for objective evaluation of glioma progression
- Blog: Resolving spatial response heterogeneity in glioblastoma
- Blog: Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F–Fluorodeoxyglucose (18F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study
- Blog: Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools?
- Blog: Deep Learning Methodology for Differentiating Glioma Recurrence From Radiation Necrosis Using Multimodal Magnetic Resonance Imaging: Algorithm Development and Validation
- Blog: Evaluation of Chemotherapy Response with Serum Squamous Cell Carcinoma Antigen Level in Cervical Cancer Patients: A Prospective Cohort Study
- Blog: Applying artificial intelligence to longitudinal imaging analysis of vestibular schwannoma following radiosurgery
- Blog: Pathological complete response in MMR-deficient/MSI-high and KRAS-mutant patient with locally advanced rectal cancer after neoadjuvant chemoradiation with immunotherapy: A case report
- Blog: Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker
- Blog: Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET
- Blog: Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps
- Blog: Noninvasive diffusion magnetic resonance imaging of brain tumour cell size for the early detection of therapeutic response
- Blog: Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
- Blog: COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake
- Blog: Radiomics and radiogenomics in gliomas: a contemporary update
- Blog: Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
- Blog: Tumor Volume Reduction Rate Predicts Pathologic Tumor Response of Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy alone: Results from a Prospective Trial
- Blog: Subtraction Maps Derived from Longitudinal Magnetic Resonance Imaging in Patients with Glioma Facilitate Early Detection of Tumor Progression
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_radiographic_pseudoprogression_a4fea57b,
title = {radiographic pseudoprogression},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/radiographic-pseudoprogression/rdr_a4fea57b5fbb4f9ea1e0328afe042325},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 2, frozen text):
@misc{lacuna_radiographic_pseudoprogression_a4fea57b_v2,
title = {radiographic pseudoprogression},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/radiographic-pseudoprogression/rdr_a4fea57b5fbb4f9ea1e0328afe042325/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-21},
}